Citation 73907

WU,YC: CHANG,GY: KO,FN: TENG,CM:. (1995). BIOACTIVE CONSTITUENTS FROM THE STEMS OF ANNONA MONTANA.. 61(2)

Citation Details

Title	BIOACTIVE CONSTITUENTS FROM THE STEMS OF ANNONA MONTANA.
Authors	WU,YC: CHANG,GY: KO,FN: TENG,CM:
Year	1995
Volume	61
Issue	2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Annona montana (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TYRAMINE,N-TRANS-FERULOYL:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-FERULOYL:	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-FERULOYL:	INACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-FERULOYL:	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-FERULOYL:	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-FERULOYL:	ACTIVE
7	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-TRANS-FERULOYL:	ACTIVE
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-TRANS-FERULOYL:	INACTIVE
9	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-TRANS-FERULOYL:	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TYRAMINE,N-PARA-COUMAROYL:	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-PARA-COUMAROYL:	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-PARA-COUMAROYL:	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-PARA-COUMAROYL:	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-PARA-COUMAROYL:	INACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-PARA-COUMAROYL:	INACTIVE
16	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-PARA-COUMAROYL:	ACTIVE
17	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-PARA-COUMAROYL:	.
18	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-PARA-COUMAROYL:	ACTIVE
19	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TYRAMINE,N-TRANS-CAFFEOYL:	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-CAFFEOYL:	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-CAFFEOYL:	INACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-CAFFEOYL:	INACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-CAFFEOYL:	INACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TYRAMINE,N-TRANS-CAFFEOYL:	INACTIVE
25	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-TRANS-CAFFEOYL:	ACTIVE
26	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-TRANS-CAFFEOYL:	INACTIVE
27	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TYRAMINE,N-TRANS-CAFFEOYL:	INACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SYRINGARESINOL,(-):	None
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGARESINOL,(-):	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGARESINOL,(-):	INACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGARESINOL,(-):	INACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGARESINOL,(-):	INACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGARESINOL,(-):	INACTIVE
34	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL,(-):	ACTIVE
35	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL,(-):	INACTIVE
36	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL,(-):	ACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SYRINGALDEHYDE	None
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGALDEHYDE	ACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGALDEHYDE	INACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGALDEHYDE	.
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGALDEHYDE	INACTIVE
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SYRINGALDEHYDE	INACTIVE
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITOSTEROL,BETA:	None
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DAUCOSTEROL	None

Citation 73907

Citation Details

Summary

Organisms and Their Experiments (1)

Annona montana (ANNONACEAE)

Show SPARQL Queries (1)

Query 1